Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06844071 · ClinicalTrials.gov registry record
The Sentio System: Post-market Evaluation of Safety and Performance in Adolescents
A clinical trial of Hearing Loss, sponsored by Oticon Medical.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT06844071: Recruiting study of Hearing Loss, sponsored by Oticon Medical.
NCT06844071 is a study of Hearing Loss that is actively recruiting participants, run by Oticon Medical. The registered enrollment target is 25 participants, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06844071, a study of Hearing Loss, is actively recruiting participants, sponsored by Oticon Medical.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a post-market, multicentre, prospective, single arm investigation aimed to systematically collect safety and performance data on the Sentio system, when used as intended for adolescents (12-17 years inclusive).
Conditions Studied
Study Locations (1)
Georgia
- Atlanta Institute for ENT - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-08-15 |
| Est. Completion | 2027-08 |
What NCT06844071 shows while recruiting
NCT06844071 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 0 interventions.
NCT06844071 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06844071 about?
NCT06844071 is a clinical study titled "The Sentio System: Post-market Evaluation of Safety and Performance in Adolescents". This study is a post-market, multicentre, prospective, single arm investigation aimed to systematically collect safety and performance data on the Sentio system, when used as intended for adolescents (12-17 years inclusive).
What is the current status of trial NCT06844071?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2025-08-15. Estimated completion is 2027-08.
What conditions does trial NCT06844071 study?
This clinical trial studies the following conditions: Hearing Loss.
Who is sponsoring clinical trial NCT06844071?
This trial is sponsored by Oticon Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06844071 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06844071's enrollment target sits among peer trials
25 52nd of 58 higher than 7 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
RECRUITING · Phase 1
-
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI